Day One Biopharmaceuticals Inc DAWN
$21.53 $0.04 (0.19%) 1D
Last Updated: Apr 22, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
DAWN Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Day One Biopharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Day One Biopharmaceuticals Inc. Stock Analysis DAWN
United States Health Care Mid Cap Day One Biopharmaceuticals, Inc. operates as a holding company. The company is headquartered in Brisbane California, California and currently employs 178 full-time employees. The company went IPO on 2021-05-27. The company partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its commercial product, OJEMDA (tovorafenib), is an oral, brain-penetrant, selective type II rapidly accelerated fibrosarcoma (RAF) kinase inhibitor. OJEMDA is used for the treatment of patients over six months of age and older with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. Its pipeline product candidates include DAY301 and Emi-Le (emiltatug ledadotin). DAY301 is a novel Antibody Drug Conjugate, or ADC, targeting protein-tyrosine kinase 7, or PTK7. Emi-Le (emiltatug ledadotin) is a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).
Day One Biopharmaceuticals Inc (DAWN) Chart
Financial Metrics & Statements of Day One Biopharmaceuticals Inc (DAWN)
FAQ's for Day One Biopharmaceuticals Inc (DAWN)
- As of August 2026, Day One Biopharmaceuticals Inc DAWN is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Day One Biopharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Day One Biopharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Day One Biopharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Day One Biopharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Day One Biopharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Day One Biopharmaceuticals Inc (DAWN)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
